These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 35077844)

  • 1. Discovery of a novel megakaryopoiesis enhancer, ingenol, promoting thrombopoiesis through PI3K-Akt signaling independent of thrombopoietin.
    Wang L; Zhang T; Liu S; Mo Q; Jiang N; Chen Q; Yang J; Han YW; Chen JP; Huang FH; Li H; Zhou J; Luo JS; Wu JM
    Pharmacol Res; 2022 Mar; 177():106096. PubMed ID: 35077844
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The combination of machine learning and transcriptomics reveals a novel megakaryopoiesis inducer, MO-A, that promotes thrombopoiesis by activating FGF1/FGFR1/PI3K/Akt/NF-κB signaling.
    Zhang T; Mo Q; Jiang N; Wu Y; Yang X; Chen W; Li Q; Yang S; Yang J; Zeng J; Huang F; Huang Q; Luo J; Wu J; Wang L
    Eur J Pharmacol; 2023 Apr; 944():175604. PubMed ID: 36804544
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel chemical-structure TPOR agonist, TMEA, promotes megakaryocytes differentiation and thrombopoiesis via mTOR and ERK signalings.
    Jiang X; Sun Y; Yang S; Wu Y; Wang L; Zou W; Jiang N; Chen J; Han Y; Huang C; Wu A; Zhang C; Wu J
    Phytomedicine; 2023 Feb; 110():154637. PubMed ID: 36610353
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thrombopoietin receptor agonist antibody for treating chemotherapy-induced thrombocytopenia.
    Shin J; Kim MJ; Quan X; Kim JW; Lee S; Park S; Jeong JY; Yea K
    BMC Cancer; 2023 May; 23(1):490. PubMed ID: 37259024
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hyperhomocysteinemia potentiates megakaryocyte differentiation and thrombopoiesis via GH-PI3K-Akt axis.
    Lei W; Liu Z; Su Z; Meng P; Zhou C; Chen X; Hu Z; Xiao A; Zhou M; Huang L; Zhang Y; Qin X; Wang J; Zhu F; Nie J
    J Hematol Oncol; 2023 Jul; 16(1):84. PubMed ID: 37501059
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting a thrombopoietin-independent strategy in the discovery of a novel inducer of megakaryocytopoiesis, DMAG, for the treatment of thrombocytopenia.
    Wang L; Liu S; Luo J; Mo Q; Ran M; Zhang T; Li X; Zou W; Mei Q; Chen J; Yang J; Zeng J; Huang F; Wu A; Zhang C; Wu J
    Haematologica; 2023 May; 108(5):1394-1411. PubMed ID: 36546424
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Novel Antithrombocytopenia Agent,
    Chen W; Zhu L; Wang L; Zeng J; Wen M; Xu X; Zou L; Huang F; Huang Q; Qin D; Mei Q; Yang J; Wang Q; Wu J
    Int J Mol Sci; 2022 Nov; 23(22):. PubMed ID: 36430539
    [TBL] [Abstract][Full Text] [Related]  

  • 8. OP9 bone marrow stroma cells differentiate into megakaryocytes and platelets.
    Matsubara Y; Ono Y; Suzuki H; Arai F; Suda T; Murata M; Ikeda Y
    PLoS One; 2013; 8(3):e58123. PubMed ID: 23469264
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activating SRC/MAPK signaling via 5-HT1A receptor contributes to the effect of vilazodone on improving thrombocytopenia.
    Zhou L; Ni C; Liao R; Tang X; Yi T; Ran M; Huang M; Liao R; Zhou X; Qin D; Wang L; Huang F; Xie X; Wan Y; Luo J; Wang Y; Wu J
    Elife; 2024 Apr; 13():. PubMed ID: 38573820
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Roles of focal adhesion kinase (FAK) in megakaryopoiesis and platelet function: studies using a megakaryocyte lineage specific FAK knockout.
    Hitchcock IS; Fox NE; Prévost N; Sear K; Shattil SJ; Kaushansky K
    Blood; 2008 Jan; 111(2):596-604. PubMed ID: 17925492
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of platelet lifespan in the presence and absence of thrombopoietin signaling.
    Lebois M; Dowling MR; Gangatirkar P; Hodgkin PD; Kile BT; Alexander WS; Josefsson EC
    J Thromb Haemost; 2016 Sep; 14(9):1882-7. PubMed ID: 27344013
    [TBL] [Abstract][Full Text] [Related]  

  • 12. M2 macrophages, but not M1 macrophages, support megakaryopoiesis by upregulating PI3K-AKT pathway activity.
    Zhao HY; Zhang YY; Xing T; Tang SQ; Wen Q; Lyu ZS; Lv M; Wang Y; Xu LP; Zhang XH; Kong Y; Huang XJ
    Signal Transduct Target Ther; 2021 Jun; 6(1):234. PubMed ID: 34140465
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Continuous expression of Bcl-xL protein during megakaryopoiesis is post-translationally regulated by thrombopoietin-mediated Akt activation, which prevents the cleavage of Bcl-xL.
    Kozuma Y; Kojima H; Yuki S; Suzuki H; Nagasawa T
    J Thromb Haemost; 2007 Jun; 5(6):1274-82. PubMed ID: 17389006
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PI3K/Akt/FOXO3a pathway contributes to thrombopoietin-induced proliferation of primary megakaryocytes in vitro and in vivo via modulation of p27(Kip1).
    Nakao T; Geddis AE; Fox NE; Kaushansky K
    Cell Cycle; 2008 Jan; 7(2):257-66. PubMed ID: 18256550
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Erythropoietin is a major regulator of thrombopoiesis in thrombopoietin-dependent and -independent contexts.
    Hacein-Bey-Abina S; Estienne M; Bessoles S; Echchakir H; Pederzoli-Ribeil M; Chiron A; Aldaz-Carroll L; Leducq V; Zhang Y; Souyri M; Louache F; Abina AM
    Exp Hematol; 2020 Aug; 88():15-27. PubMed ID: 32721504
    [TBL] [Abstract][Full Text] [Related]  

  • 16. GSK-3β negatively regulates megakaryocyte differentiation and platelet production from primary human bone marrow cells in vitro.
    Ono M; Matsubara Y; Shibano T; Ikeda Y; Murata M
    Platelets; 2011; 22(3):196-203. PubMed ID: 21231855
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thrombopoietin induces phosphoinositol 3-kinase activation through SHP2, Gab, and insulin receptor substrate proteins in BAF3 cells and primary murine megakaryocytes.
    Miyakawa Y; Rojnuckarin P; Habib T; Kaushansky K
    J Biol Chem; 2001 Jan; 276(4):2494-502. PubMed ID: 11054408
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    Yang X; Wang L; Zeng J; Wu A; Qin M; Wen M; Zhang T; Chen W; Mei Q; Qin D; Yang J; Jiang Y; Wu J
    Pharmaceuticals (Basel); 2022 Sep; 15(10):. PubMed ID: 36297316
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DMAG, a novel countermeasure for the treatment of thrombocytopenia.
    Lin J; Zeng J; Liu S; Shen X; Jiang N; Wu YS; Li H; Wang L; Wu JM
    Mol Med; 2021 Nov; 27(1):149. PubMed ID: 34837956
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of platelet factor 4 in radiation-induced thrombocytopenia.
    Lambert MP; Xiao L; Nguyen Y; Kowalska MA; Poncz M
    Int J Radiat Oncol Biol Phys; 2011 Aug; 80(5):1533-40. PubMed ID: 21740995
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.